2018 News Archive

Results of Clinical Trial PA.6 Announced in Chicago

Clinical trial results performed in Canada and France using mFOLFIRINOX have shown that patients who undergo surgical removal of pancreatic cancer cells lived on average, 20 months longer than those who received gemicitabine. – Global News

read more

Challenges for Small Charities

Challenges for Small Charities: Pancreatic Cancer Canada joins a panel discussion in response to The Toronto Foundation’s latest Vital Signs Report – The Agenda with Steve Paikin (TVO)

read more

FOR MEDIA INQUIRIES

Ali Schofield
Director, Marketing and Communications
aschofield@pccf.ca
416-548-8077 ext 1003

316-4211 Yonge Street
Toronto, ON M2P 2A9
Toll Free: 1-888-726-2269

info@pccf.ca
Charitable Registration Number 84870 1967 RR0001